Page 1 | Search Results | Blood | American Society of Hematology

1-19 of 19

Sort by

Sort Order Select

Journal Articles

Real-World Analysis of Patients with CLL Treated with Ibrutinib: A Retrospective Analysis of the Brazilian Registry of CLL

Verena Pfister, Fernanda de Morais Marques, Vinicius Campos de Molla, Flavia Parra, Mihoko Yamamoto, Rodrigo Santucci, Milton A. F. Aranha, Valeria Buccheri, Glaciano Ribeiro, Vera Figueiredo, Nelson Hamerschlak, Abel Costa Neto, Jayr Schmidt Filho, Talita Silveira, Adriana Scheliga, Matheus Vescovi Goncalves, Leila Perobelli, Carlos Chiattone, Celso Arrais-Rodrigues

Blood (2024) 144 (Supplement 1): 2348.

https://doi.org/10.1182/blood-2024-210706

Published: 2024

Journal Articles

Potential Benefits of Using the Combination of Ibet with Ibtk Chronic Lymphocytic Leukemia and Other Tumor Types

Jose Leilton C. de Carvalho, Sr., Pedro Fernandes, Fernanda de Morais Marques, Verena Pfister, Matheus Vescovi Goncalves, Ana Paula Tavares, Bruna B. Lins, Paula Asprino, Fabiana Bettoni, Cibele Masotti, Anamaria Camargo, Celso Arrais-Rodrigues, Mariane Amano

Blood (2024) 144 (Supplement 1): 6786.

https://doi.org/10.1182/blood-2024-212034

Published: 2024

Journal Articles

Outcomes of Conservative Indication Criteria for First-Line Treatment in Chronic Lymphocytic Leukemia: Insights from the Brazilian Registry of CLL

Blood (2023) 142 (Supplement 1): 6534.

https://doi.org/10.1182/blood-2023-190590

Published: 2023

Journal Articles

Real-World Outcomes of Second-Line Chronic Lymphocytic Leukemia Treatments: Retrospective Analysis of the Brazilian Registry of CLL

Marcelo Pitombeira de Lacerda, Fernanda de Morais Marques, Verena Pfister, Flavia de Carvalho Parra, Vinicius Campos de Molla, Valeria Buccheri, Rafael Dezen Gaiolla, Laura Maria Fogliatto, Rodrigo Santucci, Marcelo Bellesso, Sérgio Costa Fortier, Talita M.B. Silveira, Glaciano Ribeiro, Nelson Hamerschlak, Mihoko Yamamoto, Matheus Vescovi Goncalves, Carlos S. Chiattone, Celso Arrais-Rodrigues

Blood (2022) 140 (Supplement 1): 7041–7042.

https://doi.org/10.1182/blood-2022-170872

Published: 2022

Journal Articles

Favorable Outcome in CLL Patients Not Treated Despite Presenting Iwcll Criteria: A Retrospective Analysis of the Brazilian CLL Group

Fernanda de Morais Marques, Verena Pfister, Flavia Parra, Mihoko Yamamoto, MD PhD, Rodrigo Santucci Silva, MD, Marcelo Bellesso, MD, Vinicius Campos de Molla, MD, Ana Rita Da Fonseca, MD, Yana Novis, MD, Sérgio Costa Fortier, MD, Talita Silveira, MD PhD, Guilherme Brasil Duffles Amarante, MD, Valeria Buccheri, Matheus Vescovi, MD PhD, Carlos Sérgio Chiattone, MD PhD, Celso Arrais, MD PhD

Blood (2020) 136 (Supplement 1): 12.

https://doi.org/10.1182/blood-2020-142810

Published: 2020

Journal Articles

Comparison of Clinical and Laboratory Features, Drug Availability, and Outcomes of CLL Patients Treated in Public or in Private Hospitals in Brazil: A Retrospective Analysis of the Brazilian Registry of CLL

Blood (2020) 136 (Supplement 1): 2.

https://doi.org/10.1182/blood-2020-142520

Published: 2020

Journal Articles

Metabolomic Profile in Patients with Paroxysmal Nocturnal Hemoglobinuria

Patricia Eiko Yamakawa, MD, Ana Rita Da Fonseca, MD, Matheus Vescovi, MD PhD, Iara Baldim Rabelo Gomes, MD PhD, Ismael Dale Cotrim Guerreiro da Silva, MD PhD, Celso Arrais-Rodrigues, MD PhD

Blood (2019) 134 (Supplement_1): 2229.

https://doi.org/10.1182/blood-2019-126241

Published: 2019

Journal Articles

Subcutaneous Alemtuzumab Has Activity in Treatment-Naïve Patients with Acquired Aplastic Anemia

Ana Rita Da Fonseca, MD, Anita Hill, MD PhD, Patricia Eiko Yamakawa, MD, Iara Baldim Rabelo, MD PhD, Andre Domingues Pereira, MD, Vinicius Campos de Molla, MD, Matheus Vescovi Gonçalves, MD PhD, Morag Griffin, MD, Talha Munir, MD, Peter Hillmen, MD PhD, Louise Arnold, MD, Kathryn Riley, MD, Antonio M. Risitano, MD PhD, Phillip Scheinberg, MD, Celso Arrais-Rodrigues, MD PhD

Blood (2019) 134 (Supplement_1): 2503.

https://doi.org/10.1182/blood-2019-130719

Published: 2019

Journal Articles

NK CD56 bright CD16 neg reconstitution over Time (NK56-index) Significantly Impacts Long Term Outcome in Allogeneic Hematopoietic Stem Cell Transplantation

Dante Escorcio-Tavares, Vinicius Campos de Molla, MD, Elisa Y Kimura, Vergilio Colturato, MD, Maura V Ikoma, MD PhD, Victor Gottardello Zecchin, MD, Adriana Seber, MD, Nelson Hamerschlak, MD PhD, Vanderson Rocha, MD PhD, Yana Novis, MD, Mihoko Yamamoto, MD PhD, Marcio Nucci, MD PhD, Celso Arrais-Rodrigues, MD PhD, Matheus Vescovi Gonçalves, MD PhD

Blood (2019) 134 (Supplement_1): 3295.

https://doi.org/10.1182/blood-2019-128263

Published: 2019

Journal Articles

Classical Monocyte Deficiency Calculated By the Mono-Index Can Predict Mortality in Allogeneic Hematopoietic Stem Cell Transplantation Patients

Vinicius Campos de Molla, MD, Matheus Vescovi Gonçalves, MD PhD, Elisa Y Kimura, Vergilio Colturato, MD, Maura V Ikoma, MD PhD, Victor Gottardello Zecchin, MD, Adriana Seber, MD, Nelson Hamerschlak, MD PhD, Vanderson Rocha, MD PhD, Yana Novis, MD, Mihoko Yamamoto, MD PhD, Marcio Nucci, MD PhD, Celso Arrais-Rodrigues, MD PhD

Blood (2019) 134 (Supplement_1): 5666.

https://doi.org/10.1182/blood-2019-126221

Published: 2019

Journal Articles

Ibrutinib Maintenance after Chemoimmunotherapy Is Feasible and Results in Excellent Progression-Free and Overall Survival in Patients with Detectable MRD after Chemoimmunotherapy

Nayara Ribeiro Guedes, MD, Ana Rita Da Fonseca, MD, Thiago Xavier Carneiro, MD PhD, Vinicius Campos de Molla, MD, Rodrigo Santucci Silva, MD, Sérgio Costa Fortier, MD, Vera Lucia de Piratininga Figueiredo, MD, Larissa Ommati, MD, Valeria Buccheri, MD PhD, Gislaine Borba Oliveira, MD, Leila Martins Perobelli, MD, Fernando Sergio Blumm Ferreira, MD, Matheus Vescovi, MD PhD, Celso Arrais-Rodrigues, MD PhD

Blood (2019) 134 (Supplement_1): 1764.

https://doi.org/10.1182/blood-2019-125626

Published: 2019

Journal Articles

Molecular Genetic Classification of Brazilian Acute Myeloid Leukemia and Myelodysplastic Syndromes Patients

Aline Dos Santos Borgo Perazzio, MD PhD, Matheus Vescovi Gonçalves, MD PhD, Alex Freire Sandes, MD PhD, Maria de Lourdes Chauffaille, MD PhD

Blood (2017) 130 (Supplement 1): 5079.

https://doi.org/10.1182/blood.V130.Suppl_1.5079.5079

Published: 2017

Journal Articles

Alemtuzumab for Treatment-Naïve and Relapsed-Refractory Severe Acquired Aplastic Anemia

Nayara Ribeiro Guedes, Juliana Goncalves, MD, Marcelo Lacerda, MD, Maria Cristina Nunez, ANA RITA F B Medeiros, MD, Ana Carolina Kirchmeyer, Andre domingues Pereira, MD, Patricia Eiko Yamakawa, MD, Melca Oliveira Barros, MD PhD, Matheus Vescovi, MD PhD, Mihoko Yamamoto, MD PhD, Celso Arrais, MD PhD

Blood (2017) 130 (Supplement 1): 4961.

https://doi.org/10.1182/blood.V130.Suppl_1.4961.4961

Published: 2017

Journal Articles

Circulating Microparticles As Predictive Biomarkers of Acute Graft Versus Host Disease

Thiago Xavier Carneiro, MD, Daniella Gregolin Marrese, Melina Gonçalves dos Santos, PhD, Matheus Vescovi Gonçalves, MD PhD, Yana Sarkis Novis, MD, Edgar Gil Rizzatti, MD PhD, Vanderson Rocha, MD PhD, Alex Freire Sandes, MD PhD, Celso Arrais Rodrigues, MD PhD

Blood (2016) 128 (22): 5778.

https://doi.org/10.1182/blood.V128.22.5778.5778

Published: 2016

Journal Articles

Higher Counts Of Plasmacytoid Dendritic Cells In The Allograft Are Associated Increased Risk Of Acute Gvhd After Stem Cell Transplantation

Matheus Vescovi Gonçalves, MD, Mihoko Yamamoto, MD, PhD, Eliza Y. S. Kimura, Vergilio Antonio Renzi Colturato, Maura Valerio Ikoma, MD, PhD, Marcos Mauad, MD, Mair Pedro de Souza, Paulo Guilherme Alvarenga Gomes de Oliveira, Ana Paula Vaz Carvalho, Fabio R. Kerbauy, MD, PhD, Nelson Hamerschlak, MD, PhD, Yana Novis, MD, Valeria Cortez Ginani, MD, Adriana Seber, MD, Vanderson Rocha, MD, PhD, Alberto Orfao, MD, PhD, Celso Arrais Rodrigues, MD, PhD

Blood (2013) 122 (21): 4626.

https://doi.org/10.1182/blood.V122.21.4626.4626

Published: 2013

Journal Articles

Higher Risk Of HHV6 Reactivation Among Patients Undergoing Umbilical Cord Blood Transplantation

Paulo Guilherme Alvarenga Gomes de Oliveira, Miriam Ueda, Juliana Monte Real, MD, Eloisa de Sá Moreira, MD, Ana Paula Vaz Carvalho, Thiago Xavier Carneiro, MD, Matheus Vescovi Goncalves, MD, Luiz Fernando Lima Reis, MD, Adriana Seber, MD, Nelson Hamerschlak, MD, PhD, José Salvador Rodrigues de Oliveira, MD, PhD, Fabio R. Kerbauy, MD, PhD, Yana Novis, MD, Celso F. H. Granato, MD, Celso Arrais Rodrigues, MD, PhD

Blood (2013) 122 (21): s4649.

https://doi.org/10.1182/blood.V122.21.s4649.s4649

Published: 2013

Journal Articles

Low Counts Of Natural Killer Cells CD56 bright CD16 negative After Engraftment Are Associated With Worse Survival In Patients Receiving Allogeneic Hematopoietic Stem Cell Transplantation

Matheus Vescovi Gonçalves, MD, Mihoko Yamamoto, MD, PhD, Eliza Y. S. Kimura, Vergilio Antonio Renzi Colturato, Maura Valerio Ikoma, MD, PhD, Marcos Mauad, MD, Mair Pedro de Souza, Paulo Guilherme Alvarenga Gomes de Oliveira, Thiago Xavier Carneiro, MD, Fabio R. Kerbauy, MD, PhD, Nelson Hamerschlak, MD, PhD, Yana Novis, MD, Valeria Cortez Ginani, MD, Adriana Seber, MD, Vanderson Rocha, MD, PhD, Alberto Orfao, MD, PhD, Celso Arrais Rodrigues, MD, PhD

Blood (2013) 122 (21): 4625.

https://doi.org/10.1182/blood.V122.21.4625.4625

Published: 2013

Journal Articles

Low Counts of Plasmacytoid Dendritic Cells After Engraftment Are Associated with Higher Early Transplantation-Related Mortality in Patients Receiving Unrelated HSCT

Matheus Vescovi GonÇalves, MD, Mihoko Yamamoto, MD, PhD, Vergílio Antônio Rensi Colturato, MD, Mair Pedro de Souza, Marcos Mauad, MD, Maura Valerio Ikoma, MD, PhD, Eliza Y. S. Kimura, Fabio P. Guirao, Nelson Hamerschlak, MD, Fabio R. Kerbauy, MD, Leonardo Raul Morelli, Yana Novis, MD, valeria Cortez Ginani, MD, Adriana Seber, MD, Vanderson Rocha, MD, PhD, Alberto Orfao, MD, PhD, Celso Arrais Rodrigues, MD, PhD

Blood (2011) 118 (21): 4541.

https://doi.org/10.1182/blood.V118.21.4541.4541

Published: 2011

Journal Articles

Unrelated Cord Blood Transplantation in Patients with Hematologic Malignancies in Brazil – A Sociedade Brasileira De Transplantes De Medula Ossea and Eurocord Collaborative Study.

Blood (2009) 114 (22): 1211.

https://doi.org/10.1182/blood.V114.22.1211.1211

Published: 2009

Update search

NARROW

Publications

Format

Article Type

Topics

Date

Availability

Real-World Analysis of Patients with CLL Treated with Ibrutinib: A Retrospective Analysis of the Brazilian Registry of CLL

Potential Benefits of Using the Combination of Ibet with Ibtk Chronic Lymphocytic Leukemia and Other Tumor Types

Outcomes of Conservative Indication Criteria for First-Line Treatment in Chronic Lymphocytic Leukemia: Insights from the Brazilian Registry of CLL

Real-World Outcomes of Second-Line Chronic Lymphocytic Leukemia Treatments: Retrospective Analysis of the Brazilian Registry of CLL

Favorable Outcome in CLL Patients Not Treated Despite Presenting Iwcll Criteria: A Retrospective Analysis of the Brazilian CLL Group

Comparison of Clinical and Laboratory Features, Drug Availability, and Outcomes of CLL Patients Treated in Public or in Private Hospitals in Brazil: A Retrospective Analysis of the Brazilian Registry of CLL

Metabolomic Profile in Patients with Paroxysmal Nocturnal Hemoglobinuria

Subcutaneous Alemtuzumab Has Activity in Treatment-Naïve Patients with Acquired Aplastic Anemia

NK CD56 bright CD16 neg reconstitution over Time (NK56-index) Significantly Impacts Long Term Outcome in Allogeneic Hematopoietic Stem Cell Transplantation

Classical Monocyte Deficiency Calculated By the Mono-Index Can Predict Mortality in Allogeneic Hematopoietic Stem Cell Transplantation Patients

Ibrutinib Maintenance after Chemoimmunotherapy Is Feasible and Results in Excellent Progression-Free and Overall Survival in Patients with Detectable MRD after Chemoimmunotherapy

Molecular Genetic Classification of Brazilian Acute Myeloid Leukemia and Myelodysplastic Syndromes Patients

Alemtuzumab for Treatment-Naïve and Relapsed-Refractory Severe Acquired Aplastic Anemia

Circulating Microparticles As Predictive Biomarkers of Acute Graft Versus Host Disease

Higher Counts Of Plasmacytoid Dendritic Cells In The Allograft Are Associated Increased Risk Of Acute Gvhd After Stem Cell Transplantation

Higher Risk Of HHV6 Reactivation Among Patients Undergoing Umbilical Cord Blood Transplantation

Low Counts Of Natural Killer Cells CD56 bright CD16 negative After Engraftment Are Associated With Worse Survival In Patients Receiving Allogeneic Hematopoietic Stem Cell Transplantation

Low Counts of Plasmacytoid Dendritic Cells After Engraftment Are Associated with Higher Early Transplantation-Related Mortality in Patients Receiving Unrelated HSCT

Unrelated Cord Blood Transplantation in Patients with Hematologic Malignancies in Brazil – A Sociedade Brasileira De Transplantes De Medula Ossea and Eurocord Collaborative Study.

Email alerts

ASH Publications

American Society of Hematology

Update search

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only